Develops non-invasive vagus nerve stimulation therapies for various conditions.
electroCore, Inc., headquartered in Rockaway, New Jersey, is a medical device company at the forefront of non-invasive vagus nerve stimulation (nVNS) therapies. Specializing in the development and commercialization of innovative treatments, electroCore focuses on advancing gammaCore, its flagship product designed for the acute relief of pain associated with migraine and episodic cluster headache in adults. gammaCore Sapphire, the company's lead device, stands out as a rechargeable and reloadable handheld solution, suitable for both regular and intermittent use across extended periods.
Founded in 2005, electroCore has established itself as a key player in the medical technology sector, leveraging its expertise in neuromodulation to address unmet medical needs. The company's dedication to enhancing patient care through cutting-edge therapies underscores its commitment to innovation and excellence in medical device development. With a focus on expanding treatment options for neurological conditions, electroCore continues to advance its nVNS technology, paving the way for improved outcomes and quality of life for patients worldwide.
In addition to its pioneering gammaCore platform, electroCore pursues strategic collaborations and partnerships to further broaden its impact in healthcare. By partnering with healthcare providers and stakeholders, the company aims to advance research, expand market access, and deliver effective solutions that empower patients and healthcare professionals alike.